Emily Z. Keung

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial”.

Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(22)00638-6

N/A

2.5DataRank · unranked

77 citations

Roland L. Bassett, Devarati Mitra, Ahsan Farooqi, Caroline Hempel, Courtney Dorber +17 more

B cells and tertiary lymphoid structures promote immunotherapy response

Nature(2020)10.1038/s41586-019-1922-8

N/A

1.2DataRank · unranked

2564 citations

Sangeetha M. Reddy, Jianjun Gao, Shaojun Zhang, Rafet Başar, Rohit Thakur +55 more

B cells are associated with survival and immunotherapy response in sarcoma

Nature(2020)10.1038/s41586-019-1906-8

N/A

1.1DataRank · unranked

1854 citations

Aurélien de Reyniès, Emily Z. Keung, Tom Wei‐Wu Chen, Cheng‐Ming Sun, Julien Caldéraro +24 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT‐STS): Updated local control, late toxicities, and patient‐reported outcomes

Cancer(2024)10.1002/cncr.35542

N/A

0.632DataRank · unranked

16 citations

Devarati Mitra, Ahsan Farooqi, David Swanson, Caroline Hempel, Tiara Willis +17 more

Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.31.506051

N/A

0.300DataRank · unranked

4 citations

Alvin Shi, Ming Tang, Marcus Ho, Christopher Terranova, Kyriaki Galani +36 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8

N/A

0DataRank · unranked

130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients

Surgery Open Science(2022)10.1016/j.sopen.2022.04.004

N/A

0DataRank · unranked

12 citations

Timothy E. Newhook, Ryan W. Day, Yi‐Ju Chiang, Whitney L. Dewhurst, Elsa M. Arvide +48 more

Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases

Annals of Surgical Oncology(2022)10.1245/s10434-022-11803-x

N/A

0DataRank · unranked

11 citations

Brandon Cope, Derek J. Erstad, Yi‐Ju Chiang, Elise F. Nassif, Christopher P. Scally +6 more

The past, present, and future: the evolving role and challenges of surgery in the multimodal management of gastrointestinal stromal tumors

Gastrointestinal Stromal Tumor(2022)10.21037/gist-22-10

N/A

0DataRank · unranked

0 citations

Heather Lyu, Emily Z. Keung, Russell G. Witt

Targeting the Molecular and Immunologic Features of Leiomyosarcoma

Cancers(2023)10.3390/cancers15072099

N/A

0DataRank · unranked

27 citations

Raymond Traweek, Rossana Lazcano, Emily Z. Keung, Alexander J. Lazar, Christina L. Roland +2 more

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia

Annals of Oncology(2023)10.1016/j.annonc.2023.06.007

N/A

0DataRank · unranked

13 citations

Joshua W.D. Tobin, Yongwoo David Seo, Georgina Gener‐Ricos, Emily Z. Keung, Elizabeth M. Burton +28 more

Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership

Annals of Surgical Oncology(2023)10.1245/s10434-023-13142-x

N/A

0DataRank · unranked

4 citations

Rachel K. Voss, Yi‐Ju Chiang, Sa Nguyen, Christopher P. Scally, Patrick P. Lin +10 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer(2024)10.1038/s43018-024-00726-z

N/A

0DataRank · unranked

58 citations

Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin +54 more

Plasma DNA Methylation‐Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1

Molecular Carcinogenesis(2024)10.1002/mc.23825

N/A

0DataRank · unranked

7 citations

Manishkumar S. Patel, Angela D. Bhalla, Christine B. Peterson, Sharon M. Landers, S. Carson Callahan +20 more

Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11511

N/A

0DataRank · unranked

3 citations

Rossana Lazcano Segura, Ahsan Farooqi, Davis R. Ingram, Khalida Wani, Yiming Cai +13 more

Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience

Frontiers in Immunology(2025)10.3389/fimmu.2025.1567736

N/A

0DataRank · unranked

4 citations

Cheuk Hong Leung, Marianne Zoghbi, Rossana Lazcano, Davis R. Ingram, Khalida Wani +21 more

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma

ESMO Open(2025)10.1016/j.esmoop.2025.105493

N/A

0DataRank · unranked

1 citations

Mohamad El Zoghbi, Rossana Lazcano, Brandon Cope, Andrew J. Bishop, Ahsan Farooqi +24 more

Optimal surveillance for detecting sarcoma lung metastasis – A systematic review

Surgical Oncology Insight(2025)10.1016/j.soi.2025.100124

N/A

0DataRank · unranked

0 citations

Kate Krause, Emily Z. Keung, Heather Lyu, Heather A. Lillemoe, Christopher P. Scally +5 more

ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.23.689992

N/A

0DataRank · unranked

0 citations

Anand K. Singh, Yingda Jiang, Zheng Zhao, Davis R. Ingram, Khalida Wani +28 more

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1824

N/A

0DataRank · unranked

215 citations

Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack +18 more

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma

Cell Reports(2020)10.1016/j.celrep.2020.108293

N/A

0DataRank · unranked

70 citations

Emily Z. Keung, Ming Tang, Yan Liang, Hunain Alam, Guangchun Han +27 more

Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa012

N/A

0DataRank · unranked

28 citations

Jeffrey E. Gershenwald, Emily Z. Keung

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

Research Square(2020)10.21203/rs.3.rs-58480/v1

N/A

0DataRank · unranked

0 citations

Christopher P. Vellano, Michael White, Miles C. Andrews, Joseph R. Daniele, Mark Titus +41 more

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes

Cancers(2021)10.3390/cancers13215301

N/A

0DataRank · unranked

12 citations

Michael G. White, Russell G. Witt, Anik Banerjee, Michael A. Davies, Guangchun Han +18 more